Skip to content

Clinical trials

Central Nervous System Diseases trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Hungary Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20144
20171
20181
20202
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
AstraZeneca2
Auspex Pharmaceuticals, Inc.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Emalex Biosciences Inc.1
Guerbet1
MapLight Therapeutics1
Microvention-Terumo, Inc.1
Novartis Pharmaceuticals1
Remedy Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases15
Brain Diseases12
Nervous System Diseases11
Movement Disorders8
Mental Disorders6
Neurodegenerative Diseases6
Alzheimer Disease3
Dementia3
Neurocognitive Disorders3
Neurologic Manifestations3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.